二膦酸盐类药物治疗骨质疏松症的研究进展

被引：6

作者：

闵理

王以朋

吴志宏

机构：

[1] 中国医学科学院北京协和医学院北京协和医院

来源：

中国骨与关节外科 | 2009年 / 2卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

<正>1二膦酸盐类(bisphosphonates,BPs)药物治疗骨质疏松症的机制BPs药物是焦磷酸盐类似物,含1个磷酸盐-碳-磷酸盐(P-C-P)核心结构,该结构使其能靶向作用于骨骼并抵抗酶分解作用。将复合物侧链

引用

页码：131 / 135

页数：5

共 24 条

[1]

Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography [J].

Borah, B ;

Dufresne, TE ;

Ritman, EL ;

Jorgensen, SM ;

Liu, S ;

Chmielewski, PA ;

Phipps, RJ ;

Zhou, XJ ;

Sibonga, JD ;

Turner, RT .

BONE, 2006, 39 (02) :345-352

[2]

Pamidronate in children with osteogenesis imperfecta: Histomorphometric effects of long-term therapy [J].

Rauch, F ;

Travers, R ;

Glorieux, FH .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :511-516

[3]

Oral ibandronate in the management of postmenopausal osteoporosis: Review of upper gastrointestinal safety [J].

Epstein, S ;

Delmas, PD ;

Emkey, R ;

Wilson, KM ;

Hiltbrunner, V ;

Schimmer, RC .

MATURITAS, 2006, 54 (01) :1-10

[4]

Intravenous ibandronate injections in postmenopausal women with osteoporosis - One-year results from the dosing intravenous administration study [J].

Delmas, Pierre D. ;

Adami, Silvano ;

Strugala, Cezary ;

Stakkestad, Jacob A. ;

Reginster, Jean-Yves ;

Felsenberg, Dieter ;

Christiansen, Claus ;

Civitelli, Roberto ;

Drezner, Marc K. ;

Recker, Robert R. ;

Bolognese, Michael ;

Hughes, Claire ;

Masanauskaite, Daiva ;

Ward, Penelope ;

Sambrook, Philip ;

Reid, David M. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1838-1846

[5]

Osteonecrosis of the jaws in patients treated with bisphosphonates – histomorphologic analysis in comparison with infected osteoradionecrosis.[J].TorstenHansen;MartinKunkel;AchimWeber;C.James Kirkpatrick.Journal of Oral Pathology & Medicine.2006, 3

[6]

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis*.[J].Joyce A. Cramer;Mayur M. Amonkar;Ansgar Hebborn;Roy Altman.Current Medical Research and Opinion?.2005, 9

[7]

Combination therapy for osteoporosis: considerations and controversy. [J].